Skip to Main Content

Paper Details

Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.
Am J Hematol
2
2023
Author NameAffiliation
Rashmi Kanagal-ShamannaThe University of Texas MD Anderson Cancer Center
Hagop KantarjianThe University of Texas, MD Anderson Cancer Center
  • 1 - 2

Datasets

Release 1.2